Company intelligence / Profile preview

Sodilac

Levallois Perret, Île-de-France, Francednb.com ↗

Ownership: Private
Development stage: Other

Overview

Sodilac is a French company specializing in the development and commercialization of infant nutrition products under the brand "Modilac." The company focuses on providing safe and effective infant formulas for various dietary needs. There is no evidence of clinical trial results as it does not develop pharmaceuticals.

Therapeutic areas: Metabolic Disorders
Modalities: Protein (infant formula)Nutritional product (not a therapeutic drug modality)
Industry: Food & Nutrition

Beyond the preview

Go deeper on Sodilac.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodilac.

Explore the full profile